Results 11 to 20 of about 29,309,204 (245)
HDL-C and non-HDL-C levels are associated with anthropometric and biochemical parameters [PDF]
Jornal Vascular Brasileiro, 2019 Background Dyslipidemias are associated with atherosclerosis and cardiovascular diseases. Recently, non-high-density lipoprotein cholesterol (non-HDL-c) has emerged as a new target for assessment and prediction of risk of cardiovascular disease (CVD ...
Sandra Maria Barbalho +7 more
doaj +5 more sources
Friedewald formula may be used to calculate non-HDL-C from LDL-C and TG [PDF]
Frontiers in Medicine, 2023 BackgroundThe Friedewald formula (FF) was originally designed 50 years ago and has been in use to this day despite better methods for estimating LDL cholesterol (LDL-C). Its success was mainly due to its simplicity.
Jerzy Romaszko +2 more
doaj +4 more sources
Kidney & Blood Pressure Research, 2017 Background/Aims: Evidence indicates a role for dyslipidemia in the development of chronic kidney disease (CKD). However, the association of lipid abnormalities and their ratios with kidney disease using the new CKD Epidemiology Collaboration (CKD-EPI ...
Jia Wen +6 more
doaj +3 more sources
BMC Cardiovascular Disorders, 2021 Background A distorted blood lipid profile is an important risk factor for ischemic heart disease (IHD) but the predictive ability of the different lipid measures has rarely been studied.
Susanna Calling +4 more
doaj +3 more sources
Lipids in Health and Disease, 2018 Background Non-HDL-cholesterol to HDL-cholesterol (non-HDL-c/HDL-c) ratio is a feasible predictor for coronary heart disease, metabolic syndrome, and insulin resistance.
Dianhui Wang +5 more
doaj +2 more sources
The clinical utility of apoB versus LDL-C/non-HDL-C
Clinica Chimica Acta, 2020 The ESC/EAS Guidelines and the EAS/EFLM consensus reports state that apoB is a more accurate marker of cardiovascular risk than LDL-C or non-HDL-C and that apoB can be measured accurately and precisely than LDL-C or non-HDL-C. Nevertheless, EAS/EFLM called for a randomized clinical trial and a cost-effective analysis before widespread implementation of
Ciaran N, Kohli-Lynch +3 more
openaire +3 more sources
Elevated non-HDL-C to HDL-C ratio as a marker for NAFLD and liver fibrosis risk: a cross-sectional analysis [PDF]
Frontiers in EndocrinologyBackgroundDyslipidemia is a known independent risk factor for Nonalcoholic fatty liver disease (NAFLD). However, the relationship between NAFLD and the serum non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol ...
Yanyan Xuan +8 more
doaj +2 more sources
The relationship between non-HDL-C/HDL-C ratio and bone mineral density: an NHANES study
Frontiers in NutritionBackgroundThe non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a newly developed lipid parameter. However, the current research has only explored the relationship with lumbar spine bone mineral density ...
Shuo Qi +4 more
doaj +3 more sources
Non-HDL C equals apolipoprotein B: except when it does not!
Current Opinion in Lipidology, 2010 Whether national guidelines should incorporate apolipoprotein B (apoB) into clinical practice is one of the most important and contentious decisions they must face. Canada has chosen to do so. What Europe and America decide remains to be seen.Obviously, the results of the major epidemiological studies and clinical trials should be major drivers of ...
Sniderman, A. +2 more
openaire +4 more sources
Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences
Indian Heart Journal, 2020 Objective: The present study aimed to establish a better marker for the assessment of coronary artery disease (CAD). Methods: One hundred patients of CAD (aged 20–60 years) of both sex and patients of hypertension with symptoms of CAD were selected for ...
Gobardhan Kathariya +4 more
doaj +3 more sources